Prelude Therapeutics secures $60M from Incyte option deal
Go back to Prelude Therapeutics secures $60M from Incyte option deal| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 95.94 -1.39 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.33 | 52 Week High | $118.49 | |||
| Open | $96.23 | 52 Week Low | $55.00 | |||
| Day High | $96.30 | P/E | N/A | |||
| Day Low | $94.61 | EPS | $-0.56 | |||
| Volume | 1,255,015 | |||||
| (NASDAQ: PRLD) | Delayed: 3.23 +0.11 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.05 | 52 Week Low | $ | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.05 | EPS | $ | |||
| Volume | 249,313 | |||||
